Abstract
Patients of Tuberculosis have poor treatment outcome with high mortality. Immunodeficiency appears to be an important risk factor in the development of multi drug resistance (MDR) and extensively drug resistance (XDR) tuberculosis. Mesenchymal stromal cell (MSCs) having immunomodulatory effect, have been used as adjunct autologous treatment. Thereby, it helps in transforming chronic inflammation into productive immune response. Stem cells therapy is based on the principle, that it migrates to the site of injury and forms tissue specific cell type that can replace the damaged tissue. Autologous MSCs have been used as an adjunct treatment in MDR TB in the lungs for accelerating clearance of pathogenic bacteria and early recovery. It appears to be a promising procedure for enhancing the efficacy of anti-TB therapy in MDR and XDR subjects.
Keywords: Multi-drug resistance, extremely drug resistance, tuberculosis, mesenchymal stem cell therapy.
Current Respiratory Medicine Reviews
Title:Stem Cells in MDR-TB and XDR - TB
Volume: 10 Issue: 4
Author(s): Vijay K. Arora, Paramjit S. Dhot and P. Singhal
Affiliation:
Keywords: Multi-drug resistance, extremely drug resistance, tuberculosis, mesenchymal stem cell therapy.
Abstract: Patients of Tuberculosis have poor treatment outcome with high mortality. Immunodeficiency appears to be an important risk factor in the development of multi drug resistance (MDR) and extensively drug resistance (XDR) tuberculosis. Mesenchymal stromal cell (MSCs) having immunomodulatory effect, have been used as adjunct autologous treatment. Thereby, it helps in transforming chronic inflammation into productive immune response. Stem cells therapy is based on the principle, that it migrates to the site of injury and forms tissue specific cell type that can replace the damaged tissue. Autologous MSCs have been used as an adjunct treatment in MDR TB in the lungs for accelerating clearance of pathogenic bacteria and early recovery. It appears to be a promising procedure for enhancing the efficacy of anti-TB therapy in MDR and XDR subjects.
Export Options
About this article
Cite this article as:
K. Arora Vijay, S. Dhot Paramjit and Singhal P., Stem Cells in MDR-TB and XDR - TB, Current Respiratory Medicine Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/1573398X11666150109223613
DOI https://dx.doi.org/10.2174/1573398X11666150109223613 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MIANN Models of Networks of Biochemical Reactions, Ecosystems, and U.S. Supreme Court with Balaban-Markov Indices
Current Bioinformatics Contribution of Antimicrobial Peptides to the Development of New and Efficient Antimicrobial Strategies
Current Proteomics Gene Mining and Functional Genomics in Human Osteoarthritis
Current Genomics Beyond Providing Drugs: the Mectizan® Donation Stimulates New Strategies in Service Delivery and in Strengthening Health Systems
Current Pharmaceutical Biotechnology An Update on Autoinflammatory Diseases
Current Medicinal Chemistry The Role of Drug Transporters in the Pharmacokinetics of Antibiotics
Current Drug Metabolism Anti-mycobacterial Activity of 22 Iranian Endemic or Rare Plant Extracts Against Multi-drug and Extensively Drug-resistant <i>Mycobacterium tuberculosis</i>
Combinatorial Chemistry & High Throughput Screening Computer-Aided Discovery in Antimicrobial Research: In Silico Model for Virtual Screening of Potent and Safe Anti-Pseudomonas Agents
Combinatorial Chemistry & High Throughput Screening Treatment of Central Nervous System Tuberculosis Infections and Neurological Complications of Tuberculosis Treatment
Current Pharmaceutical Design A Review on the Phytochemicals, Ethnomedicine Uses and Pharmacology of Ficus Species
Current Traditional Medicine Foreword
Recent Patents on Anti-Infective Drug Discovery NMN/NaMN Adenylyltransferase (NMNAT) and NAD Kinase (NADK) Inhibitors: Chemistry and Potential Therapeutic Applications
Current Medicinal Chemistry Synthesis, Biological Evaluation and Computational Study of New Quinoline Hybrids as Antitubercular Agent
Letters in Drug Design & Discovery The Effects of Obesity on Drug Metabolism in Children
Drug Metabolism Letters Structure-based Virtual Screening Approaches in Kinase-directed Drug Discovery
Current Topics in Medicinal Chemistry Drugs that Inhibit Mycolic Acid Biosynthesis in Mycobacterium tuberculosis - An Update
Medicinal Chemistry Reviews - Online (Discontinued) Solid-Phase Synthesis in the Twenty-First Century
Mini-Reviews in Medicinal Chemistry Editorial (Thematic Issue: Medicinal Chemistry Studies of Neglected Diseases)
Mini-Reviews in Medicinal Chemistry Cyclodextrin-Based Delivery Systems for Arthritic Diseases: From Development to Experimental Therapeutics
Current Pharmaceutical Design Recent Advances in the Synthesis of Biologically Active Cinnoline, Phthalazine and Quinoxaline Derivatives
Current Organic Chemistry